|
73
|
284
|
1v0oA |
Structure of p. falciparum pfpk5-indirubin-5-sulphonate ligand complex |
|
80
|
286
|
1v0pA |
Structure of p. falciparum pfpk5-purvalanol b ligand complex |
|
81
|
296
|
1urcA |
Cyclin a binding groove inhibitor ace-arg-lys-leu-phe-gly |
|
80
|
286
|
1v0bA |
Crystal structure of the t198a mutant of pfpk5 |
|
79
|
298
|
1urwA |
Cdk2 in complex with an imidazo[1,2-b]pyridazine |
|
66
|
299
|
1ua2A |
Crystal structure of human cdk7 |
|
72
|
298
|
1r78A |
Cdk2 complex with a 4-alkynyl oxindole inhibitor |
|
85
|
297
|
1qmzA |
Phosphorylated cdk2-cyclyin a-substrate peptide complex |
|
82
|
298
|
1pxmA |
Human cyclin dependent kinase 2 complexed with the inhibitor 3-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol |
|
76
|
298
|
1pxnA |
Human cyclin dependent kinase 2 complexed with the inhibitor 4-[4-(4-methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol |
|
81
|
298
|
1pxlA |
Human cyclin dependent kinase 2 complexed with the inhibitor [4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-(4-trifluoromethyl-phenyl)-amine |
|
79
|
298
|
1pw2A |
Apo structure of human cyclin-dependent kinase 2 |
|
82
|
298
|
1pxoA |
Human cyclin dependent kinase 2 complexed with the inhibitor [4-(2-amino-4-methyl-thiazol-5-yl)-pyrimidin-2-yl]-(3-nitro-phenyl)-amine |
|
73
|
298
|
1pyeA |
Crystal structure of cdk2 with inhibitor |
|
76
|
298
|
1pxiA |
Human cyclin dependent kinase 2 complexed with the inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-ylamine |
|
76
|
298
|
1pxpA |
Human cyclin dependent kinase 2 complexed with the inhibitor n-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-n',n'-dimethyl-benzene-1,4-diamine |
|
74
|
298
|
1pxjA |
Human cyclin dependent kinase 2 complexed with the inhibitor 4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine |
|
78
|
298
|
1pxkA |
Human cyclin dependent kinase 2 complexed with the inhibitor n-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-n'-hydroxyiminoformamide |
|
83
|
297
|
1pkdA |
The crystal structure of ucn-01 in complex with phospho-cdk2/cyclin a |
|
74
|
298
|
1p2aA |
The structure of cyclin dependent kinase 2 (ckd2) with a trisubstituted naphthostyril inhibitor |
|
69
|
298
|
1pf8A |
Crystal structure of human cyclin-dependent kinase 2 complexed with a nucleoside inhibitor |
|
85
|
297
|
1p5eA |
The structure of phospho-cdk2/cyclin a in complex with the inhibitor 4,5,6,7-tetrabromobenzotriazole (tbs) |
|
78
|
296
|
1oirA |
Imidazopyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation |
|
89
|
300
|
1oiuA |
Structure of human thr160-phospho cdk2/cyclin a complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor |
|
79
|
296
|
1ol1A |
Cyclin a binding groove inhibitor h-cit-cit-leu-ile-(p-f-phe)-nh2 |
|
79
|
295
|
1okvA |
Cyclin a binding groove inhibitor h-arg-arg-leu-ile-phe-nh2 |
|
70
|
298
|
1oiqA |
Imidazopyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation |
|
86
|
296
|
1ol2A |
Cyclin a binding groove inhibitor h-arg-arg-leu-asn-(p-f-phe)-nh2 |
|
86
|
297
|
1oiyA |
Structure of human thr160-phospho cdk2/cyclin a complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor |
|
77
|
286
|
1ob3A |
Structure of p. falciparum pfpk5 |
|
84
|
297
|
1oi9A |
Structure of human thr160-phospho cdk2/cyclin a complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor |
|
84
|
296
|
1okwA |
Cyclin a binding groove inhibitor ac-arg-arg-leu-asn-(m-cl-phe)-nh2 |
|
70
|
296
|
1oitA |
Imidazopyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation |
|
85
|
300
|
1oguA |
Structure of human thr160-phospho cdk2/cyclin a complexed with a 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitor |
|
80
|
298
|
1ke7A |
Cyclin-dependent kinase 2 (cdk2) complexed with 3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2h-indol-2-one |
|
79
|
298
|
1ke8A |
Cyclin-dependent kinase 2 (cdk2) complexed with 4-{[(2-oxo-1,2-dihydro-3h-indol-3-ylidene)methyl]amino}-n-(1,3-thiazol-2-yl)benzenesulfonamide |
|
76
|
298
|
1ke9A |
Cyclin-dependent kinase 2 (cdk2) complexed with 3-{[4-({[amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1h-indole |
|
78
|
298
|
1ke6A |
Cyclin-dependent kinase 2 (cdk2) complexed with n-methyl-{4-[2-(7-oxo-6,7-dihydro-8h-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide |
|
76
|
298
|
1ke5A |
Cdk2 complexed with n-methyl-4-{[(2-oxo-1,2-dihydro-3h-indol-3-ylidene)methyl]amino}benzenesulfonamide |
|
76
|
298
|
1jsvA |
The structure of cyclin-dependent kinase 2 (cdk2) in complex with 4-[(6-amino-4-pyrimidinyl)amino]benzenesulfonamide |
|
83
|
298
|
1jstA |
Phosphorylated cyclin-dependent kinase-2 bound to cyclin a |
|
80
|
298
|
1jvpP |
Crystal structure of human cdk2 (unphosphorylated) in complex with pkf049-365 |
|
81
|
286
|
1jsuA |
P27(kip1)/cyclin a/cdk2 complex |
|
77
|
298
|
1hclA |
Human cyclin-dependent kinase 2 |
|
85
|
298
|
1hckA |
Human cyclin-dependent kinase 2 |
|
87
|
297
|
1h1rA |
Structure of human thr160-phospho cdk2/cyclin a complexed with the inhibitor nu6086 |
|
78
|
297
|
1h1qA |
Structure of human thr160-phospho cdk2/cyclin a complexed with the inhibitor nu6094 |
|
82
|
296
|
1h07A |
Cdk2 in complex with a disubstituted 4, 6-bis anilino pyrimidine cdk4 inhibitor |
|
80
|
298
|
1h0wA |
Human cyclin dependent protein kinase 2 in complex with the inhibitor 2-amino-6-[cyclohex-3-enyl]methoxypurine |
|
82
|
296
|
1gy3A |
Pcdk2/cyclin a in complex with mgadp, nitrate and peptide substrate |
